Grail (NASDAQ:GRAL – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55, Zacks reports. The firm had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million.
Grail Stock Up 7.4 %
Shares of GRAL stock opened at $51.29 on Friday. The stock has a 50-day simple moving average of $26.32 and a 200 day simple moving average of $19.06. Grail has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.
Wall Street Analyst Weigh In
GRAL has been the topic of several research analyst reports. Wolfe Research started coverage on Grail in a research note on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley started coverage on Grail in a research report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price on the stock.
About Grail
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Stories
- Five stocks we like better than Grail
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
- Consumer Discretionary Stocks Explained
- Gold’s Ascent: Can Miners and ETFs Take Investors to $3,000?
- Stock Market Sectors: What Are They and How Many Are There?
- Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.
